Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress in applying genomics in drug development.

Peter G Lord1

  • 1Johnson & Johnson Pharmaceutical Research & Development LLC, 1000 Route 202, P.O. Box 300, Raritan, NJ 08869, USA. plord@prdus.jnj.com

Toxicology Letters
|April 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxidative stress/reactive metabolite gene expression signature in rat liver detects idiosyncratic hepatotoxicants.

Toxicology and applied pharmacology·2014
Same author

Integrating omic technologies into aquatic ecological risk assessment and environmental monitoring: hurdles, achievements, and future outlook.

Environmental health perspectives·2010
Same author

The evolution of gene expression studies in drug safety assessment.

Toxicology mechanisms and methods·2009
Same author

Evaluation of felbamate and other antiepileptic drug toxicity potential based on hepatic protein covalent binding and gene expression.

Chemical research in toxicology·2007
Same author

Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity.

Molecular carcinogenesis·2006
Same author

Application of genomics in preclinical drug safety evaluation.

Basic & clinical pharmacology & toxicology·2006
Same journal

LEF1 regulated CTHRC1 Promotes Silica-Induced Pulmonary Fibrosis through CD44-Dependent Signaling.

Toxicology letters·2026
Same journal

hERG Channel Blockade and Additive Interactions of Magnolol and Honokiol from Magnolia Species.

Toxicology letters·2026
Same journal

Evaluation of dose-dependent hematotoxic effects of celastrol on human blood cells in vitro.

Toxicology letters·2026
Same journal

Environmental pharmaceutical and antibiotic mixtures: An exposomics-guided framework for mechanistic toxicology.

Toxicology letters·2026
Same journal

Size- and morphology-dependent cytotoxicity of metal-organic frameworks: Deciphering the structure-toxicity relationship.

Toxicology letters·2026
Same journal

Steroidogenesis suppression in H295R cells by 1,3-disubstituted ureas: A potential off-target effect of some sEH inhibitors.

Toxicology letters·2026
See all related articles

Genomics advances drug development by enabling predictive toxicology and mechanism-based risk assessment. Analyzing gene expression patterns helps identify potential drug toxicity and elucidate mechanisms of action.

Area of Science:

  • Genomics
  • Toxicology
  • Drug Development

Background:

  • Genomics offers novel approaches to predictive toxicology and mechanism-based risk assessment in drug development.
  • Gene expression profiling is key to understanding cellular responses to xenobiotics.

Purpose of the Study:

  • To highlight the impact of genomics on predictive toxicology and mechanism-based risk assessment.
  • To discuss the application of gene expression data in identifying drug toxicity and elucidating mechanisms.

Main Methods:

  • Developing databases of expression profiles for toxic compounds and models.
  • Utilizing statistical and computational methods to analyze gene expression patterns.
  • Examining gene expression changes in response to drugs in vitro and in vivo systems.

Related Experiment Videos

Main Results:

  • Genomic approaches enable the prediction of a compound's toxic potential based on gene expression changes.
  • Gene expression analysis facilitates the generation and evaluation of hypotheses regarding toxic mechanisms.
  • Toxicogenomics is a maturing technology with increasing investment in drug development.

Conclusions:

  • Genomics is integral to modern drug development, enhancing safety and mechanistic understanding.
  • Toxicogenomics provides powerful tools for predicting toxicity and understanding drug action.
  • The continued maturation and investment in toxicogenomics promise to further revolutionize drug development.